Chen Xi

I completed my Ph.D. in pharmacology at Zhejiang University, China, in June 2020, specializing in cancer immunology. My doctoral research provided in-depth training in mouse models, particularly the construction of humanized immune recombinants such as PBMC and CD34-engrafted xenografts for pharmacodynamic studies. I developed skills in in vitro drug screening, immune cell sorting, and animal models, solidifying my expertise in experimental design. Currently, I am conducting research in Dr. Wendy Béguelin's lab, focusing on the role of the tumor microenvironment in B lymphoma progression. I pioneered a multiphoton microscopy approach for real-time imaging of cellular interactions within lymphoid tissues, enabling a detailed view of cellular interactions in lymphoma. Supported by experts from the Béguelin, Chris Xu and Melnick groups, our team leverages advanced murine lymphoma models and deep-tissue imaging techniques.